North American Cannabis Holdings revealed details regarding an enthusiastic shareholder response to news that the DEA, in cooperation with the FDA, had rescheduled some applications of cannabidiol (CBD) reducing previous restrictions. The DEA announced that drugs including "finished dosage formulations" of CBD approved by the FDA containing THC below 0.1% will be considered Schedule 5 drugs. After advancing a number of cannabis sector initiatives since 2013, USMJ has recently announced a reorganization to leverage its "USMJ" brand name by launching a comprehensive online portal selling cannabis related products while positioning its existing AmeriCanna Cafe restaurant business unit for accelerated growth by spinning it off into a standalone listing where USMJ shareholders receive a dividend of spinoff stock. USMJ anticipates announcing a spinoff transaction within the next two weeks. The increased number of calls and emails in reaction to the recent DEA and FDA news communicated an eager enthusiasm for USMJ to take its next steps with the ecommerce site and AmeriCanna Cafe businesses.